NCT00597454 An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery Status COMPLETED Phase NA
NCT00597272 Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma Status COMPLETED Phase NA
NCT00597090 The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections Status COMPLETED Phase N/A
NCT00596219 Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase NA
NCT00596154 Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma Status COMPLETED Phase PHASE2
NCT00595725 Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma Status COMPLETED Phase NA
NCT00595322 Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma Status COMPLETED Phase NA
NCT00595127 Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine Status COMPLETED Phase NA
NCT00595062 Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study Status COMPLETED Phase NA
NCT00594815 Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Status COMPLETED Phase NA
NCT00594724 Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Status COMPLETED Phase NA
NCT00594633 Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors Status COMPLETED Phase PHASE1
NCT00592111 A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) Status COMPLETED Phase PHASE2
NCT00591851 Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility Status COMPLETED Phase PHASE2
NCT00591812 Evaluation of the Compress Distal Femoral Replacement System Status COMPLETED Phase PHASE1
NCT00591643 Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59) Status COMPLETED Phase PHASE1